252
Participants
Start Date
March 9, 2016
Primary Completion Date
July 25, 2019
Study Completion Date
July 25, 2019
Palbociclib
125 mg/d capsules orally for 3 out of 4 weeks in repeated cycles
Letrozole
2.5 mg/d tablets orally on a continuous regimen
Benjamin Carl Forster, North Sydney
Dr. Alexander Maxwell Menzies, North Sydney
HPS Pharmacies - North Sydney, North Sydney
Mater Hospital Sydney, North Sydney
Professor Frances Mary Boyle, North Sydney
Royal North Shore Hospital - Clinical Trials Pharmacy, St Leonards
Royal North Shore Hospital, Dept. of Medical Oncology, St Leonards
Peter MacCallum Cancer Centre Pharmacy, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Sunshine Hospital Pharmacy, St Albans
Sunshine Hospital, St Albans
Monash Health, Clayton
Icon Cancer Care Chermside, Chermside
Icon Cancer Care Wesley, Auchenflower
River City Pharmacy, Auchenflower
Icon Cancer Care South Brisbane, South Brisbane
Icon Cancer Care, Corporate Office, South Brisbane
Icon Cancer Care Southport, Southport
Flinders Medical Centre-Pharmacy Department, Bedford Park
Flinders Medical Centre, Bedford Park
Fiona Stanley Hospital, Murdoch
Pharmacy Department, Murdoch
Dr. B.R.A Institute Rotary Cancer Hospital, All India Institue of Medical Sciences, New Delhi
The Gujarat Cancer & Research Institute, M.P Shah Cancer Hospital, Ahmedabad
Sahyadri Super Speciality Hospital, Pune
Shatabdi Hospital, Nashik
Meditrina Institute Of Medical Sciences, Nagpur
Manipal Hospital, Bangalore
HealthCare Global Enterprises Ltd., Bangalore
Kasturba Hospital, Manipal
Tata Memorial Centre, Tata Memorial Hospital, Mumbai
Deenanath Mangeshkar Hospital and Research Center, Pune
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi
Apollo Speciality Hospital, Chennai
Lead Sponsor
Pfizer
INDUSTRY